Increased Rate of Stent Thrombosis and Target Lesion Revascularization After Filter Protection in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. 15-Month Follow-Up of the DEDICATION (Drug Elution and Distal Protection in ST Elevation Myocardial Infarction) Trial

Journal of the American College of Cardiology

Volumn 55, Issue 9, 2010, Pages 867-871

  Kaltoft, Anne ^a   Kelbæk, Henning ^b   Kløvgaard, Lene ^b   Terkelsen, Christian Juhl ^a   Clemmensen, Peter ^b   Helqvist, Steffen ^b   Lassen, Jens Flensted ^a   Thuesen, Leif ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

distal protection; primary PCI; stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FILTER; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART REINFARCTION; HUMAN; MALE; NEOVASCULARIZATION (PATHOLOGY); PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STENT THROMBOSIS; THERAPY EFFECT; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DENMARK; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; REOPERATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 76849109547     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.09.052     Document Type: Article

References (12)

1. Kelbæk H., Terkelsen C.J., Helqvist S., et al. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the Drug Elution and Distal Protection in ST Elevation Myocardial Infarction (DEDICATION) trial. J Am Coll Cardiol 51 (2008) 899-905
2. Stone G.W., Webb J., Cox D.A., et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 293 (2005) 1063-1072
3. Gick M., Jander N., Bestehorn H.P., et al. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 112 (2005) 1462-1469
4. Hahn J.Y., Gwon H.C., Choe Y.H., et al. Effects of balloon-based distal protection during primary percutaneous coronary intervention on early and late infarct size and left ventricular remodeling: a pilot study using serial contrast-enhanced magnetic resonance imaging. Am Heart J 153 (2007) 665-668
5. Kelbæk H., Thuesen L., Helqvist S., et al. Drug-eluting versus bare metal stents in patients with ST-segment elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial. Circulation 118 (2008) 1155-1162
6. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
7. Cura F.A., Escudero A.G., Berrocal D., et al. Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR). Am J Cardiol 99 (2007) 357-363
8. Aoki J., Lansky A.J., Mehran R., et al. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy Trial. Circulation 119 (2009) 687-698
9. Cremonesi A., Manetti R., Setacci F., Setacci C., and Castriota F. Protected carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke 34 (2003) 1936-1941
10. Reimers B., Schluter M., Castriota F., et al. Routine use of cerebral protection during carotid artery stenting: results of a multicenter registry of 753 patients. Am J Med 116 (2004) 217-222
11. Lichtlen P.R., Nikutta P., Jost S., Deckers J., Wiese B., Rafflenbeul W., and INTACT Study Group. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography. Relation to clinical events and risk factors. Circulation 86 (1992) 828-838
12. Rozenman Y., Sapoznikov D., Mosseri M., et al. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation. J Am Coll Cardiol 30 (1997) 1420-1425